Clinical Trial Update: Observational Study to Evaluate the Safety of Levemir® in Diabetes

View source ↗

Summary

Observational study to evaluate the safety of Levemir (insulin detemir) in individuals with diabetes; the study sponsor is Novo Nordisk A/S and the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED